A nurse is teaching a client about fibrocystic breasts. Which of the following statements should the nurse include in the teaching?

This question assesses knowledge of benign breast conditions and female reproductive endocrinology. One must apply understanding of how fluctuating estrogen and progesterone levels during the menstrual cycle affect breast tissue, leading to the development of fluid-filled cysts and fibrous tissue. Choice A rationale Fibrocystic breast changes are exceptionally common, affecting over half of all women at some point in their lives. They are considered a normal variation of breast tissue development rather than a rare or pathological disease state. Choice B rationale These changes are hormonally driven by the active menstrual cycle. Consequently, symptoms typically improve or resolve after menopause when estrogen and progesterone levels decrease significantly, unless the individual is utilizing exogenous hormone replacement therapy for symptom management. Choice C rationale Tissue changes are linked to cyclic hormonal fluctuations. Estrogen stimulates the proliferation of connective tissues and milk ducts, while progesterone causes fluid retention and lobular growth, leading to the characteristic tenderness and lumps found in fibrocystic breasts. Choice D rationale Fibrocystic breast changes are generally benign and do not inherently increase the statistical risk for malignancy. Most common types of cysts and fibrosis do not involve the atypical hyperplasia required to elevate the long-term risk of cancer.